165 research outputs found

    Beet curly top resistance in USDA-ARS Kimberly germplasm, 2022

    Get PDF
    Curly top caused by Beet curly top virus (BCTV) is a widespread disease problem vectored by the beet leafhopper in semiarid sugar beet production areas. Host resistance is the primary defense against this problem, but resistance in commercial cultivars is only low to intermediate. In order to identify novel sources of curly top resistance, 8 sugar beet lines produced by the USDA-ARS Kimberly sugar beet program were screened in a disease nursery in 2022. The lines were arranged in a randomized complete block design with six replications. A curly top epiphytotic was created by releasing six viruliferous beet leafhoppers per plant at the four- to six-leaf growth stage on 15 Jun. Foliar symptoms were evaluated on 6 July using a scale of 0-9 (0 = healthy and 9 = dead). Curly top symptom development was uniform and no other disease problems were evident in the plot area. The disease pressure in the test was moderately severe with good symptom development in the susceptible checks. Based on the visual rating, five of the entries contain at least some minor resistance since their ratings were lower than the susceptible checks. However, only three entries (KDH13, KDH-39/KDH13, and KDH4-9) were not significantly different from the resistant check. These three entries and the two others with minor resistance will be retested and investigated further for potential release to the general public so they can be utilized to improve BCTV resistance in commercial sugar beet cultivars

    Combined Omics Approaches Reveal Distinct Mechanisms of Resistance and/or Susceptibility in Sugar Beet Double Haploid Genotypes at Early Stages of Beet Curly Top Virus Infection

    Get PDF
    Sugar beet is highly susceptible to Beet curly top virus (BCTV) which significantly reduces yield and sugar production in the semi-arid growing regions worldwide. Sources of genetic resistance to BCTV is highly limited and primarily dependent upon seed treatment with neonicotinoids, the use of which is gradually being restricted. Through double haploid production and genetic selection, we have developed BCTV resistant breeding lines. Using BCTV resistant (R) [KDH13; Line 13, and KDH4-9; Line 4] and susceptible (S) [KDH19-17; Line 19] lines, beet leafhopper meditated natural infection, mRNA/sRNA sequencing, and metabolite analyses we demonstrate potential mechanisms of resistance against the virus. At early infection stages (2- and 6-days post inoculation), examples of differentially expressed genes highly up-regulated in the ‘R’ lines (vs. ‘S’) include EL10Ac5g10437 (inhibitor of trypsin and hageman factor), EL10Ac6g14635 (jasmonate induced protein), EL10Ac3g06016 (ribosome related), EL10Ac2g03119 (unknown) etc. Pathway enrichment analysis showed differentially expressed genes predominantly involved with peroxisome, amino acids metabolism, fatty acid degradation, amino/nucleotide sugar metabolism etc. Metabolite analysis revealed significantly higher amounts of isoflavonoid O-glycosides, flavonoid 8-C glycosides, triterpenoid, iridoid-O-glycosides in the leaves of the ‘R’ lines (vs. ‘S’). The data presented here suggest a combination of transcriptional regulation and production of antiviral metabolites might contribute to BCTV resistance. In addition, genome divergence among BCTV strains differentially affects the production of small non-coding RNAs (sncRNAs) and small peptides which may potentially affect pathogenicity and disease symptom development

    Leaf bacteriome in sugar beet show differential response against beet curly top virus during resistant and susceptible interactions

    Get PDF
    Beet curly top virus (BCTV) is an important sugar beet yield limiting disease in semi-arid production areas. Genetic resistance to BCTV is limited; therefore, identification of additional resistance associated factors is highly desired. Using 16S rRNA sequencing and BCTV resistant (R) genotypes (KDH13, KDH4-9) along with a susceptible (S) genotype (KDH19-17), we investigated leaf bacteriome changes during BCTV post inoculation (pi). At day 6 (~6 week-old plants), Cyanobacteria were predominant (~90%), whereas at week 4 (~10 week-old plants) Firmicutes (11-66%), Bacteroidetes (17-26%), and Verrucomicrobia (12-29%) were predominant and genotype dependent. Both Bacteroidetes and Verrucomicrobia, increased post infection only in the R lines. Brevibacillus increased at 6 dpi, and Akkermansia and Bacteroides at 4 wkpi in the R lines. Linear discriminant analysis Effect Size identified potential biomarkers in the R lines vs. S line. Functional profiling revealed bacterial enrichment associated with TCA cycle, polyisoprenoid, and L-methione biosynthesis pathways only in KDH4-9 at 6 dpi. At 4 wkpi, bacteria associated with tryptophan and palmitate biosynthesis in the R lines and uridine monophosphate, phosphatidyl glycerol, and phospholipid biosynthesis in the S line, were enriched. Future characterization of bacterial genera with antiviral properties will help establish their use as biocontrol agents/biomarkers against BCTV

    Regulatory roles of small non-coding RNAs in sugar beet resistance against beet curly top virus

    Get PDF
    Beet curly top virus (BCTV) mediated yield loss in sugar beets is a major problem worldwide. The circular single-stranded DNA virus is transmitted by the beet leafhopper. Genetic sources of BCTV resistance in sugar beet are limited and commercial cultivars rely on chemical treatments versus durable genetic resistance. Phenotypic selection and double haploid production have resulted in sugar beet germplasm (KDH13-13 and KDH4-9-4) that are highly resistant to BCTV. The molecular mechanism of resistance to the virus is unknown, especially the role of small noncoding RNAs (sncRNAs) during early plant-viral interaction. Using the resistant lines along with a susceptible line (KDH19-17; 19), we demonstrate the role of sugar beet miRNAs in BCTV resistance during early infection stages when symptoms are not yet visible. The differentially expressed miRNAs altered the expression of their corresponding target genes such as pyruvate dehydrogenase (EL10Ac1g02046), carboxylesterase (EL10Ac1g01087), serine/threonine protein phosphatase (EL10Ac1g01374), and LRR receptor-like (EL10Ac7g17778), that were highly expressed in the resistant lines versus susceptible lines. Pathway enrichment analysis of the miRNA target genes showed an enrichment of genes involved in glycolysis/gluconeogenesis, galactose metabolism, starch, and sucrose metabolism to name a few. Carbohydrate analysis revealed altered glucose, galactose, fructose, and sucrose concentration in the infected leaves of resistant versus susceptible lines. We also demonstrate differential regulation of BCTV derived sncRNAs in the resistant versus susceptible lines that target sugar beet genes such as LRR (EL10Ac1g01206), 7-deoxyloganetic acid glucosyltransferase (EL10Ac5g12605), and transmembrane emp24 domain containing (EL10Ac6g14074) and altered their expression. In response to viral infection, we found that plant derived miRNAs targeted BCTV capsid protein/replication related genes and showed differences in expression among resistant and susceptible lines. The data presented here demonstrate the contribution of miRNA mediated regulation of metabolic pathways and cross-kingdom RNAi in sugar beet BCTV resistance

    The Broad-band Counterpart of the Short GRB 200522A at z=0.5536z=0.5536:A Luminous Kilonova or a Collimated Outflow with a Reverse Shock?

    Get PDF
    We present the discovery of the radio afterglow and near-infrared (NIR) counterpart of the Swift short GRB 200522A, located at a small projected offset of 1\approx 1 kpc from the center of a young, star-forming host galaxy at z=0.5536z=0.5536. The radio and X-ray luminosities of the afterglow are consistent with those of on-axis cosmological short GRBs. The NIR counterpart, revealed by our HST observations at a rest-frame time of 2.3\approx2.3 days, has a luminosity of (1.31.7)×1042\approx (1.3-1.7) \times 10^{42} erg s1^{-1}. This is substantially lower than on-axis short GRB afterglow detections, but is a factor of 8\approx 8-1717 more luminous than the kilonova of GW170817, and significantly more luminous than any kilonova candidate for which comparable observations exist. The combination of the counterpart's color (iy=0.08±0.21i-y = -0.08\pm 0.21; rest-frame) and luminosity cannot be explained by standard radioactive heating alone. We present two scenarios to interpret the broad-band behavior of GRB 200522A: a synchrotron forward shock with a luminous kilonova (potentially boosted by magnetar energy deposition), or forward and reverse shocks from a 14\approx14^{\circ}, relativistic (Γ080\Gamma_0 \gtrsim 80) jet. Models which include a combination of enhanced radioactive heating rates, low-lanthanide mass fractions, or additional sources of heating from late-time central engine activity may provide viable alternate explanations. If a stable magnetar was indeed produced in GRB 200522A, we predict that late-time radio emission will be detectable starting 0.3\approx 0.3-66 years after the burst for a deposited energy of 1053\approx 10^{53} erg. Counterparts of similar luminosity to GRB 200522A associated with gravitational wave events will be detectable with current optical searches to  ⁣250\approx\!250 Mpc

    The Broad-band Counterpart of the Short GRB 200522A at z=0.5536z=0.5536:A Luminous Kilonova or a Collimated Outflow with a Reverse Shock?

    Get PDF
    We present the discovery of the radio afterglow and near-infrared (NIR) counterpart of the Swift short GRB 200522A, located at a small projected offset of 1\approx 1 kpc from the center of a young, star-forming host galaxy at z=0.5536z=0.5536. The radio and X-ray luminosities of the afterglow are consistent with those of on-axis cosmological short GRBs. The NIR counterpart, revealed by our HST observations at a rest-frame time of 2.3\approx2.3 days, has a luminosity of (1.31.7)×1042\approx (1.3-1.7) \times 10^{42} erg s1^{-1}. This is substantially lower than on-axis short GRB afterglow detections, but is a factor of 8\approx 8-1717 more luminous than the kilonova of GW170817, and significantly more luminous than any kilonova candidate for which comparable observations exist. The combination of the counterpart's color (iy=0.08±0.21i-y = -0.08\pm 0.21; rest-frame) and luminosity cannot be explained by standard radioactive heating alone. We present two scenarios to interpret the broad-band behavior of GRB 200522A: a synchrotron forward shock with a luminous kilonova (potentially boosted by magnetar energy deposition), or forward and reverse shocks from a 14\approx14^{\circ}, relativistic (Γ080\Gamma_0 \gtrsim 80) jet. Models which include a combination of enhanced radioactive heating rates, low-lanthanide mass fractions, or additional sources of heating from late-time central engine activity may provide viable alternate explanations. If a stable magnetar was indeed produced in GRB 200522A, we predict that late-time radio emission will be detectable starting 0.3\approx 0.3-66 years after the burst for a deposited energy of 1053\approx 10^{53} erg. Counterparts of similar luminosity to GRB 200522A associated with gravitational wave events will be detectable with current optical searches to  ⁣250\approx\!250 Mpc.Comment: 33 pages, 13 figures, 5 tables. Submitted to AAS Journal

    Postepidemic Analysis of Rift Valley Fever Virus Transmission in Northeastern Kenya: A Village Cohort Study

    Get PDF
    RVFV infection causes significant disease in both human and animal populations, resulting in significant agricultural, economic and public health consequences. We conducted a cohort study on residents of a high-risk area to measure human anti-RVFV seroprevalence, to identify risk factors, and to estimate the durability of prior RVFV immunity. One hundred two individuals tested for RVFV exposure before the 2006–2007 RVF outbreak were restudied to determine interval anti-RVFV seroconversion and persistence of humoral immunity since 2006. Ninety-two additional subjects were enrolled from randomly selected households to help identify risk factors for current seropositivity. Seroprevalence in the region was high (23%). 1/85 at-risk individuals restudied in the follow-up cohort had seroconverted since early 2006. 29% of newly tested individuals were seropositive. After adjustment in multivariable logistic models, age, village, and drinking raw milk were significantly associated with RVFV seropositivity. Visual impairment (defined as ≤20/80) was much more likely in the RVFV-seropositive group. Among those with previous exposure, RVFV titers remained at protective levels (>1∶40) for more than 3 years. This study highlights the high seroprevalence among Northeastern Kenyans and the ongoing surge in seroprevalence with each RVF outbreak

    Multi-band analyses of the bright GRB~230812B and the associated SN2023pel

    Full text link
    GRB~230812B is a bright and relatively nearby (z=0.36z =0.36) long gamma-ray burst that has generated significant interest in the community and therefore has been subsequently observed over the entire electromagnetic spectrum. We report over 80 observations in X-ray, ultraviolet, optical, infrared, and sub-millimeter bands from the GRANDMA (Global Rapid Advanced Network for Multi-messenger Addicts) network of observatories and from observational partners. Adding complementary data from the literature, we then derive essential physical parameters associated with the ejecta and external properties (i.e. the geometry and environment) and compare with other analyses of this event (e.g. Srinivasaragavan et al. 2023). We spectroscopically confirm the presence of an associated supernova, SN2023pel, and we derive a photospheric expansion velocity of v \sim 17×103\times10^3 km s1s^{-1}. We analyze the photometric data first using empirical fits of the flux and then with full Bayesian Inference. We again strongly establish the presence of a supernova in the data, with an absolute peak r-band magnitude Mr=19.41±0.10M_r = - 19.41 \pm 0.10. We find a flux-stretching factor or relative brightness kSN=1.04±0.09k_{\rm SN}=1.04 \pm 0.09 and a time-stretching factor sSN=0.68±0.05s_{\rm SN}=0.68 \pm 0.05, both compared to SN1998bw. Therefore, GRB 230812B appears to have a clear long GRB-supernova association, as expected in the standard collapsar model. However, as sometimes found in the afterglow modelling of such long GRBs, our best fit model favours a very low density environment (log10(nISM/cm3)=2.161.30+1.21\log_{10}({n_{\rm ISM}/{\rm cm}^{-3}}) = -2.16^{+1.21}_{-1.30}). We also find small values for the jet's core angle θcore=1.700.71+1.00 deg\theta_{\rm core}={1.70^{+1.00}_{-0.71}} \ \rm{deg} and viewing angle. GRB 230812B/SN2023pel is one of the best characterized afterglows with a distinctive supernova bump

    A shot in the Dark (Ages): a faint galaxy at z=9.76z=9.76 confirmed with JWST

    Full text link
    The appearance of galaxies over the first billion years after the Big Bang is believed to be responsible for the last dramatic change in the state of the Universe. Ultraviolet photons from galaxies within this time period - the Epoch of Reionization - ionized intergalactic Hydrogen, rendering the Universe transparent to UV radiation and ending the so-called cosmic Dark Ages, sometime after redshift z8z\sim8. The majority of ionizing photons in the first few hundred Myrs of cosmic history are thought to derive from galaxies significantly fainter than the characteristic luminosity LL^{*}. These faint galaxies are thought to be surrounded by sufficient neutral gas to prevent the escape of the Lyman-α\alpha photons that would allow confirmation with current observatories. Here we demonstrate the power of the recently commissioned James Webb Space Telescope to transform our understanding of the sources of reionization, by reporting the first spectroscopic confirmation of a very low luminosity (0.05L\sim0.05 L^{*}) galaxy at z=9.76z=9.76, observed 480 Myr after the Big Bang, via the detection of the Lyman-break and redward continuum with the NIRSpec and NIRCam instruments. The galaxy JD1 is gravitationally magnified by a factor of μ13\mu\sim13 by the foreground cluster A2744. The power of JWST and lensing allows us to peer deeper than ever before into the cosmic Dark Ages, revealing the compact (\sim150 pc) and complex morphology and physical properties of an ultrafaint galaxy (MUV=17.45M_{\rm UV}=-17.45).Comment: Submitted to Nature. 34 pages, 4 main figures, 1 supplementary figure, 2 supplementary tables. Comments are welcom

    Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

    Get PDF
    RATIONALE: Arikace is a liposomal amikacin preparation for aerosol delivery with potent Pseudomonas aeruginosa killing and prolonged lung deposition. OBJECTIVES: To examine the safety and efficacy of 28 days of once-daily Arikace in cystic fibrosis (CF) patients chronically infected with P aeruginosa. METHODS: 105 subjects were evaluated in double-blind, placebo-controlled studies. Subjects were randomised to once-daily Arikace (70, 140, 280 and 560 mg; n=7, 5, 21 and 36 subjects) or placebo (n=36) for 28 days. Primary outcomes included safety and tolerability. Secondary outcomes included lung function (forced expiratory volume at one second (FEV(1))), P aeruginosa density in sputum, and the Cystic Fibrosis Quality of Life Questionnaire—Revised (CFQ-R). RESULTS: The adverse event profile was similar among Arikace and placebo subjects. The relative change in FEV(1) was higher in the 560 mg dose group at day 28 (p=0.033) and at day 56 (28 days post-treatment, 0.093L±0.203 vs −0.032L±0.119; p=0.003) versus placebo. Sputum P aeruginosa density decreased >1 log in the 560 mg group versus placebo (days 14, 28 and 35; p=0.021). The Respiratory Domain of the CFQ-R increased by the Minimal Clinically Important Difference (MCID) in 67% of Arikace subjects (560 mg) versus 36% of placebo (p=0.006), and correlated with FEV(1) improvements at days 14, 28 and 42 (p<0.05). An open-label extension (560 mg Arikace) for 28 days followed by 56 days off over six cycles confirmed durable improvements in lung function and sputum P aeruginosa density (n=49). CONCLUSIONS: Once-daily Arikace demonstrated acute tolerability, safety, biologic activity and efficacy in patients with CF with P aeruginosa infection
    corecore